节点文献

非瓣膜性心房颤动伴左心房血栓和(或)自发超声显影患者临床特征和长期结局

Clinical features and long-term outcomes of non-valvular atrial fibrillation patients with left atrial thrombus and (or) spontaneous echocardiographic contrast

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 罗燕玲; 黄俊; 何尚飞; 黄培仙; 饶丽芬; 刘惠霞; 张丽; 马慧欣; 徐永能; 费洪文;

【Author】 LUO Yan-ling;HUANG Jun;HE Shang-fei;HUANG Pei-xian;RAO Li-fen;LIU Hui-xia;ZHANG Li;MA Hui-xin;XU Yong-neng;FEI Hong-wen;Department of Cardiology,Guangdong Cardiovascular Institute,Guangdong Province Key Laboratory of South China Structural Heart disease,Guangdong General Hospital,Guangdong Academy of Medical Sciences;Department of Geriatrics,Institute of Geriatrics,Guangdong General Hospital,Guang-dong Academy of Medical Sciences;

【通讯作者】 黄俊;

【机构】 广东省心血管病研究所心血管内科广东省人民医院(广东省医学科学院); 广东省人民医院(广东省医学科学院)广东省老年医学研究所老年医学科;

【摘要】 目的探索非瓣膜性心房颤动(房颤)患者左心房血栓(left atrial thrombus,LAT)和(或)自发超声显影(spontaneous echocardiographic contrast,SEC)临床特征及长期结局。方法 2007年7月至2015年1月期间2 625例行食道超声心动图的非瓣膜性房颤患者,91例有LAT和(或)SEC,收集其临床资料并随访,记录其抗凝依从性、LAT和(或)SEC溶解,卒中、出血、死亡等情况。结果患者初始抗凝率100%,随访(33.7±24.2)个月。服用抗凝药超过1年者60例(65.9%),超过2年者54例(59.3%)。36例患者服用抗凝药后3~6个月复查食道超声心动图,其中24(66.7%)例患者LAT和(或)SEC溶解。3例患者服用华法林期间新发缺血性脑卒中事件6次,均未遗留后遗症。23例患者服用华法林期间出现出血事件:1例为左侧基底节区脑出血;1例为消化性溃疡出血;余为小出血。2例患者死亡,1例死因为左侧基底节区脑出血、脑疝,1例为心源性猝死。结论本研究中,非瓣膜性房颤伴LAT和(或)SEC患者,抗凝治疗率及依从性相对较高,多数LAT和(或)SEC经抗凝治疗可溶解,缺血性卒中风险较低。

【Abstract】 Objectives To investigate the clinical features and long-term outcomes of non-valvular atrial fibrillation(NVAF)patients with left atrial thrombus(LAT)and(or)spontaneous echocardiographic contrast(SEC).Methods We performed transesophageal echocardiograms(TEE)in 2,625 NVAF patients from July 2007 to January 2015,and91 patients were found to have LAT and(or)SEC. Data on patients` characteristics,echocardiographic findings,outcome such as anticoagulant compliance,LAT and(or)SEC dissolution,stroke,bleeding and death were recorded.ResultsOral anticoagulation was initiated in all patients. During a follow-up of(33.7±24.2)months,65.9% patientscontinued anticoagulation therapy within 1 year,and 59.3% within 2 years. On the follow-up TEE study in 36 patients,LAT and(or)SEC resolved in 24(66.7%)patients after taking anticoagulant therapy for 3-6 months. Three patientssuffered a total of 6 ischemic strokes while taking warfarin and all recovered without obvious neurologic sequelae.Twenty-three patients had bleeding events,1 had left basal ganglia hemorrhage,hernia and subsequent dead;1 hadpeptic ulcer bleeding,21 had minor bleeding events. Two patients had died,one due to cerebral hernia caused by leftbasal ganglia cerebral hemorrhage,the other due to sudden cardiac death.ConclusionsIn our study,NVAF patients with LAT and(or)SEC have relatively higher anticoagulant rates and compliance. Most LAT and(or)SEC resolveafter anticoagulant therapy. Such patients had a lower risk of ischemic stroke when taking anticoagulant therapy.

【基金】 广州市健康医疗协同创新重大专项(项目编号:201508020261)~~
  • 【文献出处】 岭南心血管病杂志 ,South China Journal of Cardiovascular Diseases , 编辑部邮箱 ,2018年06期
  • 【分类号】R541.75
  • 【被引频次】1
  • 【下载频次】47
节点文献中: 

本文链接的文献网络图示:

本文的引文网络